Opko Health Inc Earnings

The next earnings date for Opko Health Inc is July 29, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Opko Health Inc Earnings

Report DateEstimated Earnings Per Share
07/29/2026$-0.08

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Opko Health Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
04/28/2026After Market$-0.070.99%
02/26/2026After Market$-0.0442.28%
10/29/2025After Market$0.03165.93%
07/31/2025After Market$-0.19-65.94%
04/30/2025After Market$-0.10-44.30%
02/27/2025After Market$0.01110.60%
11/07/2024After Market$-0.094.56%
08/07/2024After Market$-0.0189.58%
05/07/2024After Market$-0.12-25.00%
02/27/2024After Market$-0.09-1.24%
11/06/2023After Market$-0.11-8.91%
08/03/2023After Market$-0.0363.99%
05/03/2023After Market$-0.0274.16%
02/23/2023After Market$-0.113.93%
11/08/2022After Market$-0.11-29.72%
08/04/2022After Market$-0.14-1,828.40%
05/09/2022After Market$-0.08-41.34%
02/24/2022After Market$-0.11-444.55%
10/28/2021After Market$0100.00%
07/29/2021After Market$-0.01-154.95%
04/28/2021After Market$0.053.09%
02/18/2021After Market$0.0517.92%
10/29/2020After Market$0.04-9.91%
07/30/2020After Market$0.05174.96%
05/06/2020After Market$-0.09-0.45%
02/26/2020After Market$-0.0366.14%
11/05/2019After Market$-0.11-21.01%
08/07/2019After Market$-0.1012.66%
05/07/2019After Market$-0.13-48.57%
02/27/2019After Market$-0.09-2.86%
11/09/2018After Market$-0.0538.12%
08/07/2018After Market$-0.0185.86%
05/08/2018After Market$-0.0838.13%
03/01/2018After Market$-0.32-304.55%
11/08/2017After Market$-0.08-48.42%
08/08/2017After Market$-0.0420.79%
05/09/2017After Market$-0.06-64.84%
03/01/2017After Market$-0.0252.83%
11/07/2016After Market$-0.03-7.91%
08/08/2016After Market$0.02488.24%
05/09/2016After Market$-0.0312.54%
02/29/2016After Market$0-100.00%
11/09/2015After Market$0.04269.49%
08/05/2015After Market$-0.09-66.98%
05/11/2015After Market$-0.20-147.52%
02/27/2015After Market$-0.12-87.50%
11/07/2014---$-0.11-48.45%
08/11/2014After Market$-0.0454.75%
05/09/2014---$-0.11-12.70%
03/03/2014---$-0.0344.34%
11/11/2013After Market$-0.17-165.62%
08/09/2013---$-0.0428.06%
05/09/2013---$-0.0325.74%
03/18/2013Before Market$-0.0167.00%
11/09/2012After Market$-0.030.99%
08/09/2012---$-0.04-32.01%
05/10/2012After Market$-0.03-18.58%
03/15/2012Before Market$0.06218.81%
11/09/2011After Market$-0.03-48.51%
08/08/2011After Market$-0.0233.99%
04/02/2002---$-0.1220.79%
10/24/2001---$-0.18-11.39%
08/15/2001---$-0.18-791.09%
04/01/2001Before Market$-0.109.99%

More About Opko Health Inc

Website
https://www.opko.com
Country
USA
Full Time Employees
2,275

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

“Opko Health Inc Earnings” Can Refer to the Opko Health Inc Earnings Date

Some people say “Opko Health Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Opko Health Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Opko Health Inc Stock on the Earnings Date

If you own Opko Health Inc stock (OPK) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Opko Health Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Opko Health Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Opko Health Inc Earnings

You can contact us any time if you would like to ask questions about Opko Health Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.